[(18)F]Fluorodeoxyglucose Positron Emission Tomography Reveals a Complete Remission of Refractory Metastatic Melanoma after Therapy with Ipilimumab

Por Yordanova, Anna, Schlenkhoff, Carl, Palmedo, Holger, Essler, Markus, Ahmadzadehfar, Hojjat
Publicado no Indian J Nucl Med (2017)

Therapeutic response and side effects of repeated radioligand therapy with (177)Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer

Por Ahmadzadehfar, Hojjat, Eppard, Elisabeth, Kürpig, Stefan, Fimmers, Rolf, Yordanova, Anna, Schlenkhoff, Carl Diedrich, Gärtner, Florian, Rogenhofer, Sebastian, Essler, Markus
Publicado no Oncotarget (2016)

Theranostics in nuclear medicine practice

Por Yordanova, Anna, Eppard, Elisabeth, Kürpig, Stefan, Bundschuh, Ralph A, Schönberger, Stefan, Gonzalez-Carmona, Maria, Feldmann, Georg, Ahmadzadehfar, Hojjat, Essler, Markus
Publicado no Onco Targets Ther (2017)

Radioligand therapy of metastatic prostate cancer using (177)Lu-PSMA-617 after radiation exposure to (223)Ra-dichloride

Por Ahmadzadehfar, Hojjat, Zimbelmann, Stefanie, Yordanova, Anna, Fimmers, Rolf, Kürpig, Stefan, Eppard, Elisabeth, Gaertner, Florian C., Wei, Xiao, Hauser, Stefan, Essler, Markus
Publicado no Oncotarget (2017)

Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [(177)Lu]Lu-PSMA-617 radioligand therapy

Por Ahmadzadehfar, Hojjat, Schlolaut, Stephan, Fimmers, Rolf, Yordanova, Anna, Hirzebruch, Stefan, Schlenkhoff, Carl, Gaertner, Florian C., Awang, Zool Hilmi, Hauser, Stefan, Essler, Markus
Publicado no Oncotarget (2017)

Diagnostic accuracy of [(99m)Tc]Tc-Sestamibi in the assessment of thyroid nodules

Por Yordanova, Anna, Mahjoob, Soha, Lingohr, Philipp, Kalff, Jörg, Türler, Andreas, Palmedo, Holger, Biersack, Hans-Jürgen, Kristiansen, Glen, Farahati, Jamshid, Essler, Markus, Ahmadzadehfar, Hojjat
Publicado no Oncotarget (2017)